Literature DB >> 18781811

Bistellettazines A-C and bistellettazole A: new terpenyl-pyrrolizidine and terpenyl-imidazole alkaloids from a southern Australian marine sponge, Stelletta sp.

Mohamed El-Naggar1, Andrew M Piggott, Robert J Capon.   

Abstract

Four new alkaloids have been isolated during chemical investigations into a southern Australian marine sponge, Stelletta sp. Detailed spectroscopic analysis, supported by chemical degradation and partial synthesis, permitted structure elucidation of bistellettazines A-C ( 1- 3), the first reported examples of terpenyl-pyrrolizidine conjugates, and bistellettazole A ( 4), a unique cyclic terpenyl-imidazole conjugate. The alkaloids 1- 4 feature unprecedented carbon skeletons that are proposed to share a common convergent biosynthetic origin, arising via the biogenic equivalent of a Diels-Alder addition between two hypothetical polyenyl norsesquiterpene precursors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781811     DOI: 10.1021/ol8016512

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Synthesis and Biological Evaluation of Cremastrine and an Unnatural Analogue.

Authors:  Kristopher N Hahn; Olugbeminiyi O Fadeyi; Hyekyung P Cho; Craig W Lindsley
Journal:  Tetrahedron Lett       Date:  2012-05-10       Impact factor: 2.415

2.  Stellettapeptins A and B, HIV-inhibitory cyclic depsipeptides from the marine sponge Stelletta sp.

Authors:  Hee Jae Shin; Mohammad A Rashid; Laura K Cartner; Heidi R Bokesch; Jennifer A Wilson; James B McMahon; Kirk R Gustafson
Journal:  Tetrahedron Lett       Date:  2015-07-08       Impact factor: 2.415

3.  Synthesis of (+/-)-bistellettadine A.

Authors:  Min Yu; Susan S Pochapsky; Barry B Snider
Journal:  Org Lett       Date:  2010-02-19       Impact factor: 6.005

Review 4.  New one-pot methodologies for the modification or synthesis of alkaloid scaffolds.

Authors:  Amir E Wahba; Mark T Hamann
Journal:  Mar Drugs       Date:  2010-08-24       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.